Skip to main content

Advertisement

Log in

Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

To profile the prescription for and adherence to breast cancer-related lymphedema (BCRL) self-care modalities among breast cancer (BrCa) survivors with BCRL in a 12-month randomized weightlifting trial.

Methods

We developed a questionnaire that assessed prescription for and adherence to 10 BCRL self-care modalities that included physical therapy exercise, pneumatic compression pump, medication, lymphedema bandaging, arm elevation, self-administered lymphatic drainage, therapist-administered lymphatic drainage, compression garments, skin care, and taping. We measured prescription for and adherence to BCRL self-care modalities at baseline, 3, 6, and 12 months. Longitudinal logistic regression was used to estimate the odds ratio (OR) and 95 % confidence interval (95 % CI) associated with prescription for and adherence to BCRL modalities over time.

Results

This study included 141 BrCa survivors with BCRL. Women were prescribed an average of 3.6 ± 2.1 BCRL self-care modalities during the study. The prescription for therapist-administered lymphatic drainage (OR = 0.92, 95 % CI 0.88–0.96), pneumatic compression pump use (OR = 0.94, 95 % CI 0.89–0.98), and bandaging (OR = 0.96, 95 % CI 0.93–0.99) decreased over 12 months of follow-up. No other prescribed BCRL self-care modalities changed during the study. Over 12 months, the average adherence to all BCRL self-care modalities varied with 13, 24, 32, and 31 % of women reporting <25, 25–49, 50–74, and ≥75 % adherence, respectively. Over 12 months, there was a noticeable change from high to low adherence in self-administered lymphatic drainage, such that there was a 15 % increased likelihood of adherence <25 % compared to ≥75 % (OR = 1.15 (95 % CI 1.05–1.26); p = 0.002). The adherence patterns of all other modalities did not change over follow-up.

Conclusions

Our findings suggest the prescription for BCRL self-care modalities is variable. The average adherence to BCRL self-care was non-optimal. Future research is necessary to prepare BrCa survivors with the knowledge, skills, abilities, and resources necessary to care for this lifelong condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241

    Article  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  3. Armer JM (2005) The problem of post-breast cancer lymphedema: impact and measurement issues. Cancer Invest 23:76–83

    Article  PubMed  Google Scholar 

  4. Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27:390–397

    Article  PubMed  Google Scholar 

  5. Francis WP, Abghari P, Du W, Rymal C, Suna M, Kosir MA (2006) Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary lymph node dissection. Am J Surg 192:636–639

    Article  PubMed  Google Scholar 

  6. Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614

    Article  PubMed  CAS  Google Scholar 

  7. Wilke LG et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500

    Article  PubMed  Google Scholar 

  8. Petrek JA, Heelan MC (1998) Incidence of breast carcinoma-related lymphedema. Cancer 83(suppl):2776–2781

    Article  PubMed  CAS  Google Scholar 

  9. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27:2007–2014

    Article  PubMed  Google Scholar 

  10. Maunsell E, Brisson J, Deschenes L (1989) Psychological distress after initial treatment for breast cancer: a comparison of partial and total mastectomy. J Clin Epidemiol 42:765–771

    Article  PubMed  CAS  Google Scholar 

  11. Passik SD, McDonald MV (1998) Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 83(suppl):2817–2820

    Article  PubMed  CAS  Google Scholar 

  12. Sneeuw KC, Aaronson NK, Yarnold JR, Broderick M, Regan J, Ross G, Goddard A (1992) Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiother Oncol 25:160–166

    Article  PubMed  CAS  Google Scholar 

  13. Carter J, Raviv L, Appollo K, Baser RE, Iasonos A, Barakat RR (2010) A pilot study using the gynecologic cancer Lymphedema questionnaire (GCLQ) as a clinical care tool to identify lower extremity Lymphedema in gynecologic cancer survivors. Gynecol Oncol 117:317–323

    Article  PubMed  Google Scholar 

  14. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s health study. J Clin Oncol 26:5689–5696

    Article  PubMed  Google Scholar 

  15. McWayne J, Heiney SP (2005) Psychologic and social sequelae of secondary lymphedema: a review. Cancer 104:457–466

    Article  PubMed  Google Scholar 

  16. Ahmed RL, Schmitz KH, Prizment AE, Folsom AR (2011) Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s health study. Breast Cancer Res Treat 130:981–991

    Article  PubMed  Google Scholar 

  17. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, Kushi LH (2010) Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg 145:1055–1063

    Article  PubMed  Google Scholar 

  18. Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, Bernstein L (2009) Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat 113:383–391

    Article  PubMed  Google Scholar 

  19. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C (2009) The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 16:1959–1972

    Article  PubMed  Google Scholar 

  20. Harris SR, Hugi MR, Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema CMAJ 164:191–199

    CAS  Google Scholar 

  21. Mayrovitz HN (2009) The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 7:101–108

    Article  PubMed  Google Scholar 

  22. Petrek JA, Pressman PI, Smith RA (2000) Lymphedema: current issues in research and management. CA Cancer J Clin 50:292–307

    Article  PubMed  CAS  Google Scholar 

  23. Moseley AL, Carati CJ, Piller NB (2007) A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 18:639–646

    Article  PubMed  CAS  Google Scholar 

  24. Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Bonner C, Bond SM, Dietrich MS (2012) A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema. Breast Cancer Res Treat 131:147–158

    Article  PubMed  CAS  Google Scholar 

  25. Ridner SH, Fu MR, Wanchai A, Stewart BR, Armer JM, Cormier JN (2012) Self-management of lymphedema: a systematic review of the literature from 2004 to 2011. Nurs Res 61:291–299

    Article  PubMed  Google Scholar 

  26. Korpan MI, Crevenna R, Fialka-Moser V (2011) Lymphedema: a therapeutic approach in the treatment and rehabilitation of cancer patients. Am J Phys Med Rehabil 90:S69–S75

    Article  PubMed  Google Scholar 

  27. Lee YM, Mak SS, Tse SM, Chan SJ (2001) Lymphoedema care of breast cancer patients in a breast care clinic: a survey of knowledge and health practice. Support Care Cancer 9:634–641

    Article  PubMed  CAS  Google Scholar 

  28. Vignes S, Porcher R, Arrault M, Dupuy A (2011) Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer 19:935–940

    Article  PubMed  Google Scholar 

  29. Schmitz KH, Troxel AB, Cheville A, Grant LL, Bryan CJ, Gross CR, Lytle LA, Ahmed RL (2009) Physical activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials 30:233–245

    Article  PubMed  Google Scholar 

  30. Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664–673

    Article  PubMed  CAS  Google Scholar 

  31. Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705

    Article  PubMed  CAS  Google Scholar 

  32. Brown JC, Troxel AB, Schmitz KH (2012) Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. Oncologist 17:1120–1128

    Article  PubMed  Google Scholar 

  33. Aickin M, Gensler H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 86:726–728

    Article  PubMed  CAS  Google Scholar 

  34. Ridner SH, Dietrich MS, Kidd N (2011) Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life. Support Care Cancer 19:631–637

    Article  PubMed  Google Scholar 

  35. Vignes S, Porcher R, Arrault M, Dupuy A (2007) Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 101:285–290

    Article  PubMed  Google Scholar 

  36. Sherman KA, Koelmeyer L (2011) The role of information sources and objective risk status on lymphedema risk-minimization behaviors in women recently diagnosed with breast cancer. Oncol Nurs Forum 38:E27–E36

    Article  PubMed  Google Scholar 

  37. Sherman KA, Koelmeyer L (2012) Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology 22(5):1120–1126. doi:10.1002/pon.3111

    Article  PubMed  Google Scholar 

  38. Turner J, Hayes S, Reul-Hirche H (2004) Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol 86:141–146

    Article  PubMed  Google Scholar 

  39. Sandel SL, Judge JO, Landry N, Faria L, Ouellette R, Majczak M (2005) Dance and movement program improves quality-of-life measures in breast cancer survivors. Cancer Nurs 28:301–309

    Article  PubMed  Google Scholar 

  40. Cheville AL (2007) Current and future trends in lymphedema management: implications for women’s health. Phys Med Rehabil Clin N Am 18:539–553

    Article  PubMed  Google Scholar 

  41. Rourke LL, Hunt KK, Cormier JN (2010) Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond Engl) 6:399–406

    Article  Google Scholar 

  42. Lawenda BD, Mondry TE, Johnstone PA (2009) Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin 59:8–24

    Article  PubMed  Google Scholar 

  43. Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss MA (2009) National standards for diabetes self-management education. Diabetes Care 32(Suppl 1):S87–S94

    Article  PubMed  Google Scholar 

  44. Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, McNeely ML, Soballe PW, Berger AM, Cheville AL, Fabian C, Gerber LH, Harris SR, Johansson K, Pusic AL, Prosnitz RG, Smith RA (2012) A prospective surveillance model for rehabilitation for women with breast cancer. Cancer 118:2191–2200

    Article  PubMed  Google Scholar 

  45. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C (2012) Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 50:217–226

    Article  PubMed  Google Scholar 

Download references

Funding

This study was funded by a National Cancer Institute Grant (R01-CA106851) to KH Schmitz. BSN medical provided custom-fitted compression garments to all study participants. Neither the National Cancer Institute nor BSN medical had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest

All authors declare no conflicts of interest. The authors have full control of all the primary data and agree to allow the editors of this journal access if requested.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathryn H. Schmitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, J.C., Cheville, A.L., Tchou, J.C. et al. Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer 22, 135–143 (2014). https://doi.org/10.1007/s00520-013-1962-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-1962-9

Keywords

Navigation